Re: Global Case ID: TH201509004487 (Local Case ID: TH150901505), FU #2
Thank you for reporting to us an adverse event related to Lilly product.
We would like to collect more information to better understand the reported event.
Please respond to following questions regarding the serious adverse event – been hospitalized for 3 weeks, involving a
Female patient, 72 Yrs, who was subscribed Teriparatide, reported the event to Lilly on 10-Sep-2015. (#3408)
Thank you.
Yours sincerely,
Sasithorn Suntharo
ELI LILLY AND COMPANY
Pharmacovigilance Associate
________________________________________________________________________
Please provide the information by 21-Dec-2015:
Please try to obtain the following information from treating physician (preferable) or from initial reporter.
1. Reason for hospitalization.
2. Diagnosis for accumulation of fluid in abdomen.